TransMedics Group Inc (TMDX)
80.48
-7.88
(-8.92%)
USD |
NASDAQ |
Nov 15, 16:00
81.11
+0.63
(+0.78%)
After-Hours: 20:00
TransMedics Group Research and Development Expense (TTM): 50.26M for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 50.26M |
| June 30, 2024 | 74.34M |
| March 31, 2024 | 68.78M |
| December 31, 2023 | 63.27M |
| September 30, 2023 | 58.26M |
| June 30, 2023 | 26.73M |
| March 31, 2023 | 25.15M |
| December 31, 2022 | 26.81M |
| September 30, 2022 | 27.37M |
| June 30, 2022 | 25.72M |
| March 31, 2022 | 25.31M |
| December 31, 2021 | 22.30M |
| Date | Value |
|---|---|
| September 30, 2021 | 20.54M |
| June 30, 2021 | 19.53M |
| March 31, 2021 | 17.14M |
| December 31, 2020 | 18.83M |
| September 30, 2020 | 20.54M |
| June 30, 2020 | 21.33M |
| March 31, 2020 | 22.21M |
| December 31, 2019 | 19.87M |
| September 30, 2019 | 17.09M |
| June 30, 2019 | 15.43M |
| March 31, 2019 | 14.07M |
| December 31, 2018 | 13.66M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
17.14M
Minimum
Mar 2021
74.34M
Maximum
Jun 2024
32.72M
Average
25.23M
Median
Research and Development Expense (TTM) Benchmarks
| Inari Medical Inc | 104.11M |
| Cutera Inc | 18.38M |
| Stereotaxis Inc | 9.182M |
| Electromed Inc | 0.656M |
| Myomo Inc | 4.090M |